Eosinophil granule cationic proteins regulate the classical pathway of complement.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Immunology

• Publication date

  1995-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 7750997PMCID PMC1415100
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Eosinophil granule cationic proteins regulate complement. I. Activity on the alternative pathway.

  1992cited by this paper
• Heparin and modified heparin inhibit complement activation in vivo.

  1992cited by this paper
• Spontaneous activation of serum C1 in vitro. Role of C1 inhibitor.

  1991cited by this paper
• Antithrombin III regulates complement activity in vitro.

  1991cited by this paper
• Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge. Characterization of eosinophil and mast cell mediators.

  1991cited by this paper
• Eosinophilia myalgia syndrome: I. Immunocytochemical evidence for a T‐cell–mediated immune effector response

  1991cited by this paper
• Comparison of the activity of polyanions and polycations on the classical and alternative pathways of complement.

  1989cited by this paper
• The activated eosinophil in allergy and asthma.

  1989cited by this paper
• A mechanism for the spontaneous activation of the first component of complement, C1, and its regulation by C1-inhibitor.

  1988cited by this paper
• Eosinophil granule major basic protein regulates generation of classical and alternative-amplification pathway C3 convertases in vitro.

  1988cited by this paper
• Description, mechanisms and control of reactions to treatment in the human filariases.

  1987cited by this paper
• Biochemical properties of the eosinophil cationic protein and demonstration of its biosynthesis in vitro in marrow cells from patients with an eosinophilia.

  1986cited by this paper
• The cytotoxic eosinophil cationic protein (ECP) has ribonuclease activity.

  1986cited by this paper
• Ribonuclease activity associated with human eosinophil-derived neurotoxin and eosinophil cationic protein.

  1986cited by this paper
• Small heparin fragments regulate the amplification pathway of complement.

  1985cited by this paper
• Human eosinophil peroxidase: purification and characterization.

  1985cited by this paper
• Episodic angioedema associated with eosinophilia.

  1984cited by this paper
• Localization of a molecule immunochemically similar to eosinophil major basic protein in human placenta

  1984cited by this paper
• Distinctive cationic proteins of the human eosinophil granule: major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin.

  1983cited by this paper
• Polyions regulate the alternative amplification pathway of complement.

  1983cited by this paper
• Spontaneous activation of the first component of human complement (C1) by an intramolecular autocatalytic mechanism.

  1982cited by this paper
• Purification of human eosinophil-derived neurotoxin.

  1981cited by this paper
• Immunologic reactivity in the hypereosinophilic syndrome.

  1979cited by this paper
• Modulation of the formation of the amplification convertase of complement, C3b, Bb, by native and commercial heparin

  1978cited by this paper
• Partial characterization of in vivo chemotactic activity: comparison to human C5a.

  1977cited by this paper
• Dangerous reactions to treatment of onchocerciasis with diethylcarbamazine.

  1977cited by this paper
• Comparative properties of the Charcot-Leyden crystal protein and the major basic protein from human eosinophils.

  1976cited by this paper
• Mode of interaction of different polyanions with the first (C1, C1), the second (C2) and the fourth (C4) component of complement--I. Effect on fluid phase C1 and on C1 bound to EA or to EAC4.

  1976cited by this paper
• Mode of interaction of different polyanions with the first (C1, C1), the second (C2) and the fourth (C4) component of complement--II. Effect of polyanions on the binding of C2 to EAC4b.

  1976cited by this paper
• Mode of interaction of different polyanions with the first (C1, C1), the second (C2) and the fourth (C4) component of complement--III. Inhibition of C4 and C2 binding site(s) on C1s by polyanions.

  1976cited by this paper
• Studies on the inhibition of C56-induced lysis (reactive lysis). VI. Modulation of C56-induced lysis polyanions and polycations.

  1975cited by this paper
• Complement activation by interaction of polyanions and polycations. I. Heparin-protamine induced consumption of complement.

  1975cited by this paper
• Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum.

  1966cited by this paper

• Local microRNAs in peritoneal dialysis-related peritonitis

  2019cites this paper
• The Eosinophil in Infection

  2016cites this paper
• Eosinophils: Biological Properties and Role in Health and Disease

  2008cites this paper
• Antibody to eosinophil cationic protein suppresses dextran sulfate sodium-induced colitis in rats.

  2005cites this paper
• IDENTIFICACIÓ IMMUNOLÒGICA I CARACTERITZACIÓ DE LES PROPIETATS BIOLÒGIQUES DE LA PROTEÏNA CATIÒNICA D'EOSINÒFIL

  2004cites this paper
• New aspects of degranulation and fates of airway mucosal eosinophils.

  2000cites this paper
• Three-dimensional crystal structure of human eosinophil cationic protein (RNase 3) at 1.75 A resolution.

  2000cites this paper
• Quantification and characterization of pregnancy-associated complexes of angiotensinogen and the proform of eosinophil major basic protein in serum and amniotic fluid.

  2000cites this paper
• Churg‐Strauss syndrome

  1999cites this paper
• Allergen-induced eosinophil cytolysis is a primary mechanism for granule protein release in human upper airways.

  1999cites this paper
• Cytolysis and piecemeal degranulation as distinct modes of activation of airway mucosal eosinophils.

  1998cites this paper
• The eosinophil ribonucleases

  1998cites this paper
• THROMBOSIS IN CHTJRG-STRAUS S SYNDROME. BEYOND VASCULTTIS?

  1996cites this paper
• Eosinophils in allergy: role in disease, degranulation, and cytokines.

  1996cites this paper
• Thrombosis in Churg-Strauss syndrome. Beyond vasculitis?

  1996cites this paper